Back

dr. W.A.M. (Willeke) Blokx

dr. W.A.M. (Willeke) Blokx

Assistant Professor - medical

Show full profile

Research Output (94)

Response to letter Re:Response to checkpoint inhibition and targeted therapy in melanoma patients with concurrent haematological malignancies

van Not Olivier J, Blokx Willeke A M, Wouters Michel W J M, Suijkerbuijk Karijn P M 1 Aug 2023, In: European Journal of Cancer. 191 , p. 112983 1 p.

A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors

van Not Olivier J, Wind Thijs T, Ismail Rawa K, Bhattacharya Arkajyoti, Jalving Mathilde, Blank Christian U, Aarts Maureen J B, van den Berkmortel Franchette W P J, Boers-Sonderen Marye J, van den Eertwegh Alfonsus J M, de Groot Jan Willem B, Haanen John B, Kapiteijn Ellen, Bloem Manja, Piersma Djura, van Rijn Rozemarijn S, Stevense-den Boer Marion, van der Veldt Astrid A M, Vreugdenhil Gerard, Wouters Michel W J M, Blokx Willeke A M, Suijkerbuijk Karijn P M, Fehrmann Rudolf S N, Hospers Geke A P 26 May 2023, In: Cancers. 15 12 p.

Clinical, histopathological and molecular features of dedifferentiated melanomas:An EORTC Melanoma Group Retrospective Analysis

Hench Juergen, Mihic-Probst Daniela, Agaimy Abbas, Frank Stephan, Meyer Peter, Hultschig Claus, Simi Sara, Alos Lucia, Balamurugan Thiagarajah, Blokx Willeke, Bosisio Francesca, Cappellesso Rocco, Griewank Klaus, Hadaschik Eva, van Kempen Leon C, Kempf Werner, Lentini Maria, Mazzucchelli Luca, Rinaldi Gaetana, Rutkowski Piotr, Schadendorf Dirk, Schilling Bastian, Szumera-Cieckiewicz Anna, van den Oord Joost, Mandalà Mario, Massi Daniela, 2 Apr 2023, In: European Journal of Cancer. 187 , p. 7-14 8 p.

Melanocytoom, intermediair tussen naevus en melanoom

van den Broeke Lieselotte R, Ebbelaar Chiel F, Hayes Donal P, Bousema Mente T, Blokx Willeke A M 29 Mar 2023, In: Nederlands Tijdschrift voor Geneeskunde. 167

Response to checkpoint inhibition and targeted therapy in melanoma patients with concurrent haematological malignancies

Van Not Olivier J, van den Eertwegh Alfons J M, Haanen John B, van Rijn Rozemarijn S, Aarts Maureen J B, van den Berkmortel Franchette W P J, Blank Christian U, Boers-Sonderen Marye J, van Eijs Mick J M, de Groot Jan-Willem B, Hospers Geke A P, Kapiteijn Ellen, de Meza Melissa, Piersma Djura, Stevense-den Boer Marion, van der Veldt Astrid A M, Vreugdenhil Gerard, Wouters Michel W J M, Suijkerbuijk Karijn P M, Blokx Willeke A M 16 Mar 2023, In: European Journal of Cancer. 186 , p. 27-37 11 p.

Adjuvant Treatment of In-Transit Melanoma:Narrowing the Knowledge Gap Left by Clinical Trials

de Meza Melissa M, Blokx Willeke A M, Bonenkamp Han J, Blank Cristian U, Aarts Maureen J B, van den Berkmortel Franchette W P J, Boers-Sonderen Marye J, de Groot Jan Willem B, Haanen John B, Hospers Geke A P, Kapiteijn Ellen W, van Not Olivier J, Piersma Djura, van Rijn Rozemarijn S, Stevense-den Boer Marion A, van der Veldt Astrid A M, Vreugdenhil Gerard, van den Eertwegh Alfons J M, Suijkerbuijk Karijn P M, Wouters Michel W J M 26 Feb 2023, In: International Journal of Cancer. 153 , p. 389-398 10 p.

CT radiomics compared to a clinical model for predicting checkpoint inhibitor treatment outcomes in patients with advanced melanoma

Ter Maat Laurens S, van Duin Isabella A J, Elias Sjoerd G, Leiner Tim, Verhoeff Joost J C, Arntz Eran R A N, Troenokarso Max F, Blokx Willeke A M, Isgum Ivana, de Wit Geraldine A, van den Berkmortel Franchette W P J, Boers-Sonderen Marye J, Boomsma Martijn F, van den Eertwegh Fons J M, de Groot Jan Willem B, Piersma Djura, Vreugdenhil Art, Westgeest Hans M, Kapiteijn Ellen, van Diest Paul J, Pluim Josien P W, de Jong Pim A, Suijkerbuijk Karijn P M, Veta Mitko 24 Feb 2023, In: European Journal of Cancer. 185 , p. 167-177 11 p.

Development and validation of risk calculators for people with "thin" melanomas on their skin to predict the likelihood that their cancer will return:a plain language summary of publication

Sharouni Mary-Ann El, Lo Serigne N, Varey Alexander Hr, Elias Sjoerd G, Witkamp Arjen J, Sigurdsson Vigfús, Suijkerbuijk Karijn Pm, van Diest Paul J, van Gils Carla H, Blokx Willeke Am, Scolyer Richard A, Thompson John F Jan 2023, In: Future Oncology. 19 , p. 97-102 6 p.

Adjuvant BRAF-MEK Inhibitors versus Anti PD-1 Therapy in Stage III Melanoma:A Propensity-Matched Outcome Analysis

De Meza Melissa M., Blokx Willeke A.M., Bonenkamp Johannes J., Blank Christian U., Aarts Maureen J.B., van den Berkmortel Franchette W.P.J., Boers-Sonderen Marye J., De Groot Jan Willem B., Haanen John B.A.G., Hospers Geke A.P., Kapiteijn Ellen, Van Not Olivier J., Piersma Djura, Van Rijn Rozemarijn S., Stevense-den Boer Marion, Van der Veldt Astrid A.M., Vreugdenhil Gerard, Van den Eertwegh Alfonsus J.M., Suijkerbuijk Karijn P.M., Wouters Michel W.J.M. Jan 2023, In: Cancers. 15

Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanoma

van Duin Isabella A.J., Elias Sjoerd G., van den Eertwegh Alfonsus J.M., de Groot Jan Willem B., Blokx Willeke A.M., van Diest Paul J., Leiner Tim, Verhoeff Joost J.C., Verheijden Rik J., van Not Olivier J., Aarts Maureen J.B., van den Berkmortel Franchette W.P.J., Blank Christian U., Haanen John B.A.G., Hospers Geke A.P., Kamphuis Anna M., Piersma Djura, van Rijn Rozemarijn S., van der Veldt Astrid A.M., Vreugdenhil Gerard, Wouters Michel W.J.M., Stevense-den Boer Marion A.M., Boers-Sonderen Marye J., Kapiteijn Ellen, Suijkerbuijk Karijn P.M. 2023, In: International Journal of Cancer. 152 , p. 2493-2502 10 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Contact

Afspraken

Praktisch

hetwkz.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not